Basic Ponstan Information

• INN (International Nonproprietary Name): Mefenamic acid
• Brand Names Available In Canada (English): not specified
• ATC Code: M01AG01
• Forms & Dosages: Capsules 250 mg; Tablets 250 mg and 500 mg; Oral suspension 50 mg/5 mL and 100 mg/5 mL (available in some markets)
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions; some OTC availability in select Asian markets depending on formulation

Major 2022–2025 Canadian & Global Studies

Worried whether new research changes how ponstan or mefenamic acid is used?

Few large new randomized controlled trials specifically for mefenamic acid appeared between 2022 and 2025.

Most evidence in that period comes from older RCTs, observational cohorts and pharmacovigilance updates reported internationally.

Canadian-specific trials are limited, while international cohorts in the EU and India report continued use for dysmenorrhea and short-term acute pain.

Recent meta-analyses from 2022–2024 compared fenamates to other NSAIDs and found comparable analgesic efficacy for single-dose pain relief.

Pooled analyses signalled a higher rate of gastrointestinal adverse events with fenamates versus ibuprofen in some datasets.

Main messages from the literature support rapid onset for menstrual cramp relief but emphasise class safety concerns.

Pharmacovigilance reports from 2022–2025 reinforced known GI and renal risks without prompting major new Health Canada warnings.

Clinicians should balance effective dysmenorrhea control against NSAID safety profiles when choosing between ponstan, ibuprofen or naproxen.

Main Outcomes

Is ponstan effective for cramps and short pain flares?

Studies consistently report rapid onset of pain relief for primary dysmenorrhea with mefenamic acid.

Typical regimens in trials show a 500 mg loading dose followed by 250 mg every six hours providing effective single-dose analgesia.

Short treatment courses, often ≤72 hours per menstrual period, maintained a favourable benefit-risk in trial settings.

Comparative reviews place fenamates alongside other NSAIDs for analgesic efficacy in acute settings.

Safety Observations

What safety signals emerged recently?

Post‑market surveillance between 2022–2025 emphasised gastrointestinal bleeding, elder vulnerability and renal concerns consistent with NSAID class effects.

No major new Canadian-specific safety advisories were issued during that window, but Health Canada continues routine monitoring.

Prescribers should remain alert for bleed risk especially in older patients or those on interacting drugs such as anticoagulants.

Layman’s Explanation

What does ponstan do when cramps feel unbearable?

Mefenamic acid is a nonsteroidal anti‑inflammatory drug that reduces prostaglandin production to lower inflammation and pain signalling.

Prostaglandins are chemical messengers that drive uterine contractions, so lowering them eases menstrual cramp pain.

People often feel relief within a few hours after taking an appropriate dose for dysmenorrhea.

Scientific Breakdown

How does mefenamic acid work at the molecular level?

Mefenamic acid is a fenamate that non‑selectively inhibits cyclooxygenase enzymes, COX‑1 and COX‑2, reducing prostaglandin synthesis.

The fenamate chemical class gives mefenamic acid slightly different tissue distribution and potency compared with propionic acids such as ibuprofen or naproxen.

COX‑1 inhibition explains common gastrointestinal effects and influences platelet function.

Pharmacokinetics (Brief)

How the body handles mefenamic acid matters for dosing and safety.

Oral capsules and tablets (commonly 250 mg) reach peak plasma levels within two to four hours after a dose.

Metabolism is hepatic with renal and biliary excretion of metabolites.

Use caution in hepatic or renal impairment because clearance may change.

Implications

Why do side effects occur and who is most at risk?

COX‑1 inhibition accounts for gastric mucosal damage and altered platelet function, increasing bleeding risk.

Elderly patients and those on anticoagulants or with prior GI disease have elevated risk of serious adverse events.

Health Canada Approvals (DIN-Based)

Can ponstan be picked up from a Canadian pharmacy like any pill?

In Canada, mefenamic acid products are generally prescription-only in most jurisdictions.

For provincial reimbursement and dispensing, clinicians and pharmacists check the drug identification number and monograph details.

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ determine coverage and listing criteria.

International brand names include Ponstel, Ponstan and various generics labelled as mefenamic acid or Acidum mefenamicum in some EU listings.

Notable Off-Label Trends In Canadian Practice

Are Canadian prescribers using ponstan for anything beyond cramps?

Off‑label but observed uses include short‑term management of postoperative dental pain or musculoskeletal strains when first‑line NSAIDs are unsuitable.

Some Canadian clinicians select mefenamic acid for severe dysmenorrhea resistant to ibuprofen or naproxen based on clinical experience.

These choices are driven more by practice patterns than by new, large RCTs within Canada.

General Dosing Per Health Canada Monographs

How should adults dose ponstan for menstrual cramps or acute pain?

Typical adult dosing is a 500 mg loading dose followed by 250 mg every six hours as required.

Do not exceed the recommended maximum and limit duration to short courses where possible.

Treatment for primary dysmenorrhea usually begins at onset of menses and continues for two to three days.

Condition-Specific Dosing Adjustments

Are children or teens treated the same way?

Pediatric oral suspensions exist in some markets, with concentrations such as 50 mg/5 mL or 100 mg/5 mL, but children under 14 are generally not recommended to use mefenamic acid due to limited safety data.

For acute mild‑to‑moderate pain in adolescents ≥14 years, the 500 mg then 250 mg q6h regimen applies.

Courses typically do not exceed one week for non‑menstrual pain.

Special Populations

Who needs extra caution when using ponstan?

Elderly patients should use the lowest effective dose for the shortest duration and be monitored for renal and GI complications.

Renal or hepatic impairment calls for caution and, in severe cases, avoidance.

Contraindications (Canadian Advisories)

Who should never take mefenamic acid?

Absolute contraindications include known hypersensitivity to mefenamic acid, NSAIDs or salicylates.

It is contraindicated in aspirin‑sensitive asthma, active peptic ulcer or GI bleeding, severe renal or hepatic impairment, and for peri‑operative pain following coronary artery bypass graft surgery.

Clinicians should always confirm product monograph and DIN details before prescribing.

Adverse Effects (Post‑Market Reports)

What side effects do patients report after taking ponstan?

Common, mild-to-moderate effects include stomach pain, dyspepsia, nausea, headache, dizziness and mild skin rash.

Rare but serious events reported post‑market include GI bleeding, acute renal injury, severe hypersensitivity and fluid retention with elevated blood pressure.

Recent pharmacovigilance from 2022–2025 continues to flag GI and renal events, especially with prolonged use, advanced age, and polypharmacy.

Food Interactions Common In Canadian Diet

Should mefenamic acid be taken with food or on an empty stomach?

Food typically slows absorption but can reduce gastric irritation, so taking the tablet with food or milk is common pharmacy advice to reduce dyspepsia.

High salt intake and alcohol consumption can increase GI and renal risks and should be moderated while taking any NSAID.

Drug Combinations Flagged By Health Canada

Which common medicines must be screened during dispensing?

Major interactions include anticoagulants and antiplatelets such as warfarin or DOACs that increase bleeding risk.

Combining mefenamic acid with other NSAIDs or aspirin raises additive bleeding and GI risk.

ACE inhibitors, ARBs and diuretics can have reduced renal function when combined with NSAIDs.

Drugs such as lithium and methotrexate may have reduced clearance and higher toxicity, while SSRIs increase GI bleeding risk.

Community pharmacies routinely screen for these interactions during prescription reviews.

Canadian Survey Data

Do Canadians like ponstan for period pain?

National surveys and dispensing reports indicate most Canadian users obtain mefenamic acid by prescription for dysmenorrhea.

Reported satisfaction is high when mefenamic acid relieves cramps that failed to respond to first‑line NSAIDs.

Adverse-event reporting rates to Health Canada remain low but align with expected NSAID-class frequencies.

Forum & Community Pharmacy Trends

What do patients and pharmacists say in the real world?

Community forums and pharmacy consultations show patients often report rapid relief within hours for menstrual cramping after taking mefenamic acid.

Common patient complaints include stomach upset and occasional drowsiness.

Pharmacists usually recommend trying ibuprofen first and position ponstan as an alternative when other NSAIDs are ineffective or poorly tolerated.

National Pharmacy Chains And Availability

Where can ponstan or its generic be bought in Canada?

Branded Ponstel may be discontinued in Canada and the United States, while generics of mefenamic acid 250 mg remain available via chains and independent pharmacies.

Provincial formularies vary, so check DIN listings and provincial drug plans such as ODB and PharmaCare for coverage options.

Large national chains like Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs may stock generics subject to supplier availability.

Online Pharmacy Availability & Provincial Restrictions

Can online pharmacies ship mefenamic acid across provinces?

Online prescription services in Canada can dispense generics with a valid prescription and comply with provincial pharmacy laws for cross‑provincial shipping.

Packaging for federally regulated products requires bilingual labelling where applicable.

In our online pharmacy, ponstan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Cross‑Border US Comparisons

Is pricing or availability different when compared to the United States?

Ponstel has been discontinued as a brand in some US areas while generics remain available internationally.

Price variability exists between Canadian retail prices and out‑of‑pocket costs in the US, which drives occasional cross‑border purchasing.

Cross‑border import is subject to personal import limits and Health Canada guidance and may not be recommended for regulated prescription medicines.

Comparison Table Of DIN‑Approved Alternatives

What else is used for cramps and short pain flares?

• Common alternatives include ibuprofen, naproxen, diclofenac and ketoprofen, with paracetamol as a non‑NSAID option.
• Choice depends on efficacy needs, GI and cardiovascular risk, and patient comorbidities or contraindications.

Pros And Cons Checklist

How does mefenamic acid compare in practical terms?

Mefenamic acid: effective for dysmenorrhea but may carry higher GI and renal risk versus ibuprofen in some analyses.

Ibuprofen: well‑studied with OTC availability, but may be less effective for severe dysmenorrhea in some patients.

Naproxen: longer duration of action but has cardiovascular considerations to weigh.

Acetaminophen: safer for GI tract but lacks anti‑inflammatory benefit and may be less effective for cramp pain.

Health Canada Approval Process

How are mefenamic acid products authorised for sale in Canada?

Products require a New Drug Submission or DIN listing and Health Canada evaluates safety, efficacy and labelling, including bilingual requirements.

No major new national market authorizations for the Ponstel brand were reported between 2022 and 2025, while generics remain authorised based on manufacturer submissions.

DIN And Bilingual Labelling Rules

What must pharmacists check before dispensing?

Products sold in Canada must carry a drug identification number and meet bilingual labelling standards when federally regulated.

Provincial pharmacies verify DIN and monograph before dispensing and manufacturers must apply separately for provincial formulary inclusion.

Consolidated FAQ

Q1: Is Ponstan/Ponstel available in Canada?

A1: Branded Ponstel may be limited or discontinued; generic mefenamic acid 250 mg is available by prescription in many markets—confirm DIN and provincial coverage.

Q2: Can I buy mefenamic acid over‑the‑counter in Canada?

A2: It is generally prescription‑only in Canada; some other countries permit OTC forms—consult your local pharmacy and Health Canada guidance.

Q3: Is it safe during breastfeeding?

A3: Data are limited; short‑term use may be acceptable with clinician advice, but avoid use in neonates or mothers with renal or hepatic compromise.

Q4: How long can I take it?

A4: Short courses are typical: up to one week for acute pain and two to three days per menstrual period; longer use increases GI and renal risks.

Q5: What if I’m on blood thinners?

A5: Combining with anticoagulants elevates bleeding risk and should not be done without prescriber oversight.

Visual Guide Recommendations

Would a visual summary help patients and staff?

Recommended infographics include a dosage timeline for dysmenorrhea, a provincial coverage map and a quick safety checklist showing contraindications and when to seek emergency care.

Design notes: use clear icons for GI risk, renal caution and age restrictions and include bilingual labels and the generic name “mefenamic acid / Acidum mefenamicum”.

Simple bar comparisons versus ibuprofen and naproxen help patients weigh efficacy against safety.

Storage And Transport

How should mefenamic acid be stored at home and during shipping?

Store tablets and capsules at controlled room temperature, 20–25°C (68–77°F), and protect them from moisture and heat.

Keep medication in the original container and out of reach of children and pets.

There is no cold‑chain requirement for standard oral forms, while some liquid suspensions may carry additional storage notes in their markets.

Dispose of unused medication through community pharmacy take‑back programs where available.

Guidelines For Proper Use

What practical counselling points do Canadian pharmacists give?

Confirm the indication, review comorbidities such as GI disease, renal or cardiovascular conditions, and check for interacting medications including anticoagulants, ACE inhibitors and SSRIs.

Recommend the lowest effective dose for the shortest required duration and advise taking mefenamic acid with food to reduce stomach upset.

Encourage patients to report adverse events to Health Canada via MedEffect and to contact their prescriber if bleeding, severe abdominal pain or decreased urine output develops.

Follow provincial formularies and document the DIN and bilingual patient information when dispensing.

Delivery Across Canada (English)

Final Practical Notes

When counselling patients, always check the product monograph and DIN for up‑to‑date local prescribing information.

Consider alternative NSAIDs or acetaminophen if gastrointestinal or renal risks outweigh expected benefits for a given patient.

Document indications and counsel patients on signs of serious adverse events and safe disposal options.

For prescription or purchase questions, direct patients to their community pharmacist or prescriber for individual advice.